-+ 0.00%
-+ 0.00%
-+ 0.00%

BRISTOL MYERS SHARES UP 3.7% PREMARKET AFTER CO'S CANCER THERAPY MEETS MAIN GOAL IN LATE-STAGE STUDY, LUNG DRUG SHOWS BENEFIT IN TRIAL

Reuters·10/12/2026 12:35:03